Perspectives on liver failure: Past and future

Seminars in Liver Disease

Volumn 28, Issue 2, 2008, Pages 137-141

  Riordan, Stephen M ^a   Williams, Roger ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Acute liver failure; Cell death; Liver support

Indexed keywords

CHARCOAL;

CELL DEATH; DISEASE COURSE; EXTRACORPOREAL CIRCULATION; HEMODIALYSIS; HEMOPERFUSION; HUMAN; INTENSIVE CARE UNIT; LIVER CELL; LIVER FAILURE; LIVER INJURY; LIVER REGENERATION; LIVER SUPPORT; MORTALITY; PATHOGENESIS; PLASMAPHERESIS; PLEIOTROPY; PRIORITY JOURNAL; REVIEW; SURVIVAL RATE; TREATMENT OUTCOME;

APOPTOSIS; HUMANS; INTENSIVE CARE; LIVER FAILURE; LIVER TRANSPLANTATION; LIVER, ARTIFICIAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 43049121406     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1073113     Document Type: Review

References (45)

1. Trey C, Davidson CS. The management of fulminant hepatic failure. In: Popper H, Schaffner F, eds. Progress in Liver Failure. New York: Grune and Stratton; 1970:282-298
2. Bernuau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis 1986;6:97-106
3. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993;342:273-275
4. O'Grady JG, Alexander GJM, Hayllar KM, et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989;97:439-445
5. Kiley JE, Pender JC, Welch HF, Welch CS. Ammonia intoxication treated by haemodialysis. N Engl J Med 1958;259:1156-1161
6. Opolon P, Rapin JR, Huguet C, et al. Hepatic failure coma (HFC) treated by polyacrylnitrile membrane (PAN) haemodialysis (HD). Trans Am Soc Artif Intern Organs 1976;22:701-710
7. Lee C, Tink A. Exchange transfusion in hepatic coma: report of a case. Med J Aust 1958;45:40-42
8. Trey C, Burns DG, Saunders SJ. Treatment of hepatic coma by exchange blood transfusion. N Engl J Med 1966;274:473-481
9. Larsen FS, Hansen BA, Ejlersen E, et al. Cerebral blood flow, oxygen metabolism and transcranial Doppler sonography during high-volume plasmapheresis in fulminant liver failure. Eur J Gastroenterol Hepatol 1996;8:261-265
10. Pascher A, Sauer IM, Neuhaus P. Analysis of allogeneic versus xenogeneic auxiliary organ perfusion in liver failure reveals superior efficacy of human livers. Int J Artif Organs 2002;25:1006-1012
11. Burnell JM, Dawborn JK, Epstein RB, et al. Acute hepatic coma treated by cross-circulation or exchange transfusion. N Engl J Med 1967;276:935-943
12. Chang TMS. Hemoperfusions over a microencapsulated adsorbent in a patient with hepatic coma. Lancet 1972;2:1371-1372
13. Riordan SM, Kurtovic J, Williams R. Fulminant hepatic failure. In: Schiff ER, Sorrell MF, Maddrey WC, eds. Schiff's Diseases of the Liver. 10th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2007:601-636
14. Chirito E, Reiter B, Lister C, Chang TMS. Artificial liver: the effect of ACAC microencapsulated charcoal haemoperfusion on fulminant hepatic failure. Artif Organs 1977;1:76-83
15. Chang TMS, Lister C, Chirito E, O'Keefe P, Resurreccion E. Effects of haemoperfusion rate and time of initiation of ACAC charcoal haemoperfusion on the survival of fulminant hepatic failure rats. Trans Am Soc Artif Intern Organs 1978;24:243-245
16. Tabata Y, Chang TMS. Comparisons of six artificial liver support regimes in fulminant hepatic coma rats. Trans Am Soc Artif Intern Organs 1980;26:394-399
17. Niu Z, Shu CD, Jia SR, Li SM. Factors possibly influencing the effects of hemoperfusion in fulminant hepatic failure rats. In: Piskin E, Chang TMS, eds. Past, Present and Future of Artificial Organs. Ankara: Meteksan Publishing; 1983:140-151
18. Gelfand MC, Winchester JF, Knepshield JH, et al. Biochemical correlates of reversal of hepatic coma coated with charcoal hemoperfusion. Trans Am Soc Artif Intern Organs 1978;24:239-242
19. Kennedy HJ, Greaves M, Triger DR. Clinical experience with the use of charcoal haemoperfusion: is prostacyclin required? Life Support Syst 1985;3:115-122
20. Tygstrup N, Ranek L. Fulminant hepatic failure. Clin Gastroenterol 1981;10:191-208
21. O'Grady JG, Gimson AE, O'Brien CJ, et al. Controlled trials of charcoal haemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 1988;94:1186-1192
22. Demetriou AA, Brown RS, Busuttil RW, et al. Prospective, randomised, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 2004;239:660-670
23. Ellis AJ, Hughes RD, Wendon JA, et al. Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology 1996;24:1446-1451
24. Catalina MV, Barrio J, Anaya F, et al. Hepatic and systemic haemodynamic changes after MARS in patients with acute on chronic liver failure. Liver Int 2003;23(suppl 3):39-43
25. Camus C, Lavoue S, Gacouin A, et al. Molecular adsorbent recirculating system dialysis in patients with acute liver failure who are assessed for liver transplantation. Intensive Care Med 2006;32:1817-1825
26. Rifai K, Ernst T, Kretschmer U, et al. Prometheus: a new extracorporeal system for the treatment of liver failure. J Hepatol 2003;39:984-990
27. Schiodt FV, Atillasoy E, Shakil AO, et al. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg 1999;5:29-34
28. Shakil AO, Kramer D, Mazariegos GV, Fung JJ, Rakela J. Acute liver failure: clinical features, outcome analysis and applicability of prognostic criteria. Liver Transpl 2000;6:163-169
29. Riordan SM, Williams R. Use and validation of selection criteria for liver transplantation in acute liver failure. Liver Transpl 2000;6:170-173
30. Bernal W, Wendon J. Intracranial hypertension in acute liver failure: prevalence and risk factors for development. Hepatology 2004;40(suppl 1):219A
31. Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002;137:947-954
32. Rolando N, Wade J, Davalos M, et al. The systemic inflammatory response syndrome in acute liver failure. Hepatology 2000;32:734-739
33. Tofteng F, Jorgensen L, Hamsen BA, et al. Cerebral microdialyis in patients with fulminant hepatic failure. Hepatology 2002;36:1333-1340
34. Shawcross DL, Davies NA, Williams R, Jalan R. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol 2004;40:247-254
35. Bernal W. Changing patterns of causation and the use of transplantation in the United Kingdom. Semin Liver Dis 2003;23:227-237
36. O'Grady J. Acute liver failure. In: O'Grady J, Lake J, Howdle P, eds. Comprehensive Clinical Hepatology. London: Mosby, 2000:30.20-30.31
37. Bonkovsky HL. Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinensis). Ann Intern Med 2006;144:68-71
38. Molinari M, Watt KD, Kruszyna T, et al. Acute liver failure induced by green tea extracts: case report and review of the literature. Liver Transpl 2006;12:1892-1895
39. Jimenez-Saenz M, Martinez-Sanchez C. Green tea extracts and acute liver failure: the need for caution in their use and diagnostic assessment. Liver Transpl 2007;13:1067
40. Bernal W, Ma Y, Smith HM, Portmann B, Wendon J, Vergani D. The significance of autoantibodies and immunoglobulins in acute liver failure: a cohort study. J Hepatol 2007;47:664-670
41. Riordan SM, Williams R. Mechanisms of hepatocyte injury, multiorgan failure and prognostic criteria in acute liver failure. Semin Liver Dis 2003;23:203-215
42. Overturf K, Al-Dhalimy M, Tanguay R, et al. Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I. Nat Genet 1996;12:266-273
43. Overturf K, Al-Dhalimy M, Ou CN, Finegold M, Grompe M. Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes. Am J Pathol 1997;151:1273-1280
44. Petersen BE, Bowen WC, Patrene KD, et al. Bone marrow as a potential source of hepatic oval cells. Science 1999;284:1168-1170
45. Strom SC, Roy Chowdhury J, Fox IJ. Hepatocyte transplantation for the treatment of human disease. Semin Liver Dis 1999;19:39-48